An anti-glypican 3/CD3 bispecific T cell-redirecting antibody for treatment of solid tumors

Ishiguro, T; Sano, Y; Komatsu, S; Kamata-Sakurai, M; Kaneko, A; Kinoshita, Y; Shiraiwa, H; Azuma, Y; Tsunenari, T; Kayukawa, Y; Sonobe, Y; Ono, N; Sakata, K; Fujii, T; Miyazaki, Y; Noguchi, M; Endo, M; Harada, A; Frings, W; Fujii, E; Nanba, E; Narita

Nezu, J (reprint author), Chugai Pharmabody Res Pte Ltd, 3 Biopolis Dr, Synapse 138623, Singapore.

SCIENCE TRANSLATIONAL MEDICINE, 2017; 9 (410):

Abstract

Cancer care is being revolutionized by immunotherapies such as immune checkpoint inhibitors, engineered T cell transfer, and cell vaccines. The bispec......

Full Text Link